Form 8-K - Current report:
SEC Accession No. 0001104659-25-062162
Filing Date
2025-06-24
Accepted
2025-06-24 17:09:42
Documents
13
Period of Report
2025-06-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518700d1_8k.htm   iXBRL 8-K 42007
2 EXHIBIT 3.1 tm2518700d1_ex3-1.htm EX-3.1 8119
  Complete submission text file 0001104659-25-062162.txt   223935

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ganx-20250624.xsd EX-101.SCH 3038
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20250624_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20250624_pre.xml EX-101.PRE 22374
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2518700d1_8k_htm.xml XML 3907
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 251070078
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)